Can we reduce the intensity of frontline therapy?
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
18 Oct 2018
Management of relapsed T-ALL in children
Prof Josef Vormoor - Newcastle University, Newcastle, UK
18 Oct 2018
CAR-T cells: challenges and opportunities
Dr Sara Ghorashian - University College London, London, UK
18 Oct 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
24 Jun 2018
Onset and treatment of infantile leukaemia
Dr Anindita Roy - University of Oxford, Oxford, UK
17 Jun 2018
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
Dr Jing Pan - Beijing Boren Hospital, Beijing, China
16 Jun 2018
Dabrafenib halts growth of low-grade paediatric glioma
Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA
4 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Nelarabine in newly diagnosed paediatric T-cell malignancies
Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA
2 Jun 2018
Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy
Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA
25 Apr 2018
Results from GOBACK: Non-chromosomal birth defects linked with cancer
Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA
25 Apr 2018
